INSULIN DEGLUDEC

Important: Therapy notes


Important: Formulation and dosage details

Formulation:

Solution for injection 100 units/mL

  • 3mL cartridge (Tresiba Penfill® for NovoPen®6 or NovoPen® Echo Plus)
  • 3mL pre-filled pen (Tresiba FlexTouch®)

Important: Formulation and dosage details

Formulation:

Solution for injection 200unit/mL

  • 3mL pre-filled pen (Tresiba FlexTouch®)

INSULIN DETEMIR

Important: Formulation and dosage details

Formulation:

Injection 100 units/mL (specialist use only)

  • 3mL cartridge (Levemir® for NovoPen® 6  or NovoPen® Echo Plus)
  • 3mL pre-filled disposable injection device (Levemir® FlexPen®, InnoLet®

INSULIN GLARGINE

Important: Therapy notes

Insulin glargine 300 units/mL (Toujeo®) has similar efficacy but is not bioequivalent to insulin glargine 100 units/mL (Abasaglar®, Lantus®) and is therefore not interchangeable without dose adjustment. When changing to Toujeo®, patients should start with the same insulin glargine dose then a small dose titration may be needed.

Important: Formulation and dosage details

Formulation:

Injection 100 units/mL

  • 10mL vial (Lantus®)
  • 3mL cartridge (Abasaglar® for HumaPen®) (Lantus for AllStar®)
  • 3mL pre-filled pen (Abasaglar® KwikPen®) (Lantus SoloStar®)

Important: Formulation and dosage details

Formulation:

Injection 300 units/mL (specialist use only)

  • 1·5mL pre-filled pen (Toujeo® SoloStar®
  • 3mL pre-filled pen (Toujeo® DoubleStar®)

Editorial Information

Document Id: F172